Leah Hoffmann

Leah Hoffmann is BTG's Content Strategist. A former journalist, Leah worked for Forbes.com and The Economist before joining BTG. She is passionate about clear thinking, sharp writing, and strong points of view.

  • Navigating a New Reality: Commercial Strategy and COVID-19

    Navigating a New Reality: Commercial Strategy and COVID-19

    Commercial strategy leaders must prepare now to ensure success for potential COVID-19 treatments. Biopharma expert Marc Cooley shares what life science companies should keep in mind at this moment.

    Read
  • Navigating a New Reality: Pharmaceutical Detailing in a Digital World

    Navigating a New Reality: Pharmaceutical Detailing in a Digital World

    COVID-19 is sidelining the field reps that life science companies rely on for in-person pharmaceutical detailing. Healthcare marketing strategist Martine Taylor discusses how eDetailing can help.

    Read
  • Navigating a New Reality: Pharmaceutical Detailing in a Digital World

    Navigating a New Reality: Pharmaceutical Detailing in a Digital World

    COVID-19 is sidelining the field reps that life science companies rely on for in-person pharmaceutical detailing. Healthcare marketing strategist Martine Taylor discusses how eDetailing can help.

    Read
  • Navigating a New Reality: Life Science and Pharma Supply Chains in the Era of COVID-19

    Navigating a New Reality: Life Science and Pharma Supply Chains in the Era of COVID-19

    Sandy Torrekens—Lead Strategist for the UK Dept. of Health during the “Swine Flu” pandemic—joins us to discuss how life science and pharma companies can respond to COVID-19 supply chain disruption.

    Read
  • Navigating a New Reality: Life Science and Pharma Supply Chains in the Era of COVID-19

    Navigating a New Reality: Life Science and Pharma Supply Chains in the Era of COVID-19

    Sandy Torrekens—Lead Strategist for the UK Dept. of Health during the “Swine Flu” pandemic—joins us to discuss how life science and pharma companies can respond to COVID-19 supply chain disruption.

    Read
  • Navigating a New Reality: Stabilizing Your Supply Chain

    Navigating a New Reality: Stabilizing Your Supply Chain

    Global supply chains are severely strained by the coronavirus (COVID-19) pandemic. Supply chain and manufacturing specialist Rosemary Coates discusses how companies can address the disruption.

    Read
  • Navigating a New Reality: Maintaining Business Continuity in the Time of COVID-19

    Navigating a New Reality: Maintaining Business Continuity in the Time of COVID-19

    Continuity expert Kathleen McGrorty joins us to discuss how executives can mitigate risk, create resilient business models, and protect operations in the face of the coronavirus (COVID-19) pandemic.

    Read
  • Navigating a New Reality: Stabilizing Your Supply Chain

    Navigating a New Reality: Stabilizing Your Supply Chain

    Global supply chains are severely strained by the coronavirus (COVID-19) pandemic. Supply chain and manufacturing specialist Rosemary Coates discusses how companies can address the disruption.

    Read
  • Navigating a New Reality: Maintaining Business Continuity in the Time of COVID-19

    Navigating a New Reality: Maintaining Business Continuity in the Time of COVID-19

    Continuity expert Kathleen McGrorty joins us to discuss how executives can mitigate risk, create resilient business models, and protect operations in the face of the coronavirus (COVID-19) pandemic.

    Read
  • Navigating a New Reality: How to Adapt Your Business Strategy to the Coronavirus Pandemic

    Navigating a New Reality: How to Adapt Your Business Strategy to the Coronavirus Pandemic

    Innovation expert Steve Wunker joins BTG's Leah Hoffmann to discuss how companies can adapt business strategies to the Coronavirus pandemic and all the upheaval that it has brought.

    Read
  • Navigating a New Reality: How to Adapt Your Business Strategy to the Coronavirus Pandemic

    Navigating a New Reality: How to Adapt Your Business Strategy to the Coronavirus Pandemic

    Innovation expert Steve Wunker joins BTG's Leah Hoffmann to discuss how companies can adapt business strategies to the coronavirus (COVID-19) pandemic and all the upheaval that it has brought.

    Read
  • Guide to Strategy Consulting

    Guide to Strategy Consulting

    What is strategy consulting? In this guide, we’ll unpack what strategy consultants do—and help you navigate an increasingly cluttered landscape.

    Read
  • Sales Process Mapping

    Sales Process Mapping

    An F500 technology company was combining its sales and delivery functions. Concerned about the difficulty of merging two very different processes while incorporating the customer perspective, the...

    Read
  • Why Work With Independent Clinical Operations Consultants?

    Why Work With Independent Clinical Operations Consultants?

    Speed is key in life science product development. Delays cost, as do mistakes. With independent clinical operations consultants, neither has to be an issue.

    Read
  • Pharmacovigilance Best Practices: A Q&A With Kerry Coffee

    Pharmacovigilance Best Practices: A Q&A With Kerry Coffee

    Independent life science consultant Kerry Coffee shares best practices for building efficient pharmacovigilance organizations and leveraging AI.

    Read
  • Pharma Product Launch Best Practices

    Pharma Product Launch Best Practices

    Independent biopharma marketer Kimberly Crichton explains how technology is changing the way life science companies launch products and communicate with consumers and healthcare providers.

    Read
  • Independent Consulting: A User’s Guide

    Independent Consulting: A User’s Guide

    Independent consulting helps companies boost organizational agility, access hard-to-hire skills, and move faster on critical projects. Unfortunately, there’s still a lot of confusion about what it is.

    Read
  • Strategic Workforce Planning: Behind the Buzzword

    Strategic Workforce Planning: Behind the Buzzword

    Strategic workforce planning has emerged as a critical way for HR and business leaders to deliver on broader business goals. But what is it?

    Read
  • Building Data Science Applications: A Q&A With Aaron Barzilai

    Building Data Science Applications: A Q&A With Aaron Barzilai

    Independent data scientist and basketball analytics expert Aaron Barzilai discusses best practices for building data science applications.

    Read
  • Pharmaceutical Target Valuation

    Pharmaceutical Target Valuation

    The head of M&A at a global pharma company was evaluating an acquisition target based in India. His team had already assessed the company’s core business, but it needed help understanding the...

    Read
  • loading
    Loading More...